TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27334385

Group type: EXPERIMENTAL
Intervention: FMR1 premutation carriers (PC)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: FMR1 premutation carriers (PC) with FXTAS
Number of subjects: 397

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 397
Study: 24906863

Group type: EXPERIMENTAL
Intervention: Medications
Number of subjects: 607

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 607
Study: 22397614

Group type: EXPERIMENTAL
Intervention: Peer-led dementia educational intervention for GPs (two educational sessions from a peer GP or nurse)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Peer-led dementia educational intervention for GPs
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Waitlist group receiving RACGP Guidelines by post
Number of subjects: 2000
Study: 20979935

Group type: EXPERIMENTAL
Intervention: Levodopa/carbidopa/entacapone (LCE) 200
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled-release levodopa/carbidopa (CR-LC) 200
Number of subjects: 0
Study: 18923991

Group type: EXPERIMENTAL
Intervention: Clobex Spray (CP spray)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Olux Foam (CP foam)
Number of subjects: 77
Study: 15961302

Group type: EXPERIMENTAL
Intervention: Enteral feeding
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Enteral plus parenteral feeding
Number of subjects: 60

Group type: COMPARATOR
Intervention: Only parenteral feeding
Number of subjects: 60

Group type: COMPARATOR
Intervention: TPN therapy
Number of subjects: 60
Study: 12354335

Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional chest physiotherapy (CPT)
Number of subjects: 46
Study: 10195534

Group type: EXPERIMENTAL
Intervention: Active millimeter wave generator (MW)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Disabled sham generator (control)
Number of subjects: 12
Study: 7786700

Group type: EXPERIMENTAL
Intervention: Collagen-sealed Dacron graft
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gelatin-impregnated Dacron graft
Number of subjects: 20
Study: 2179479

Group type: EXPERIMENTAL
Intervention: multidrug chemotherapy schedule with VM26 and AraC
Number of subjects: 21

Group type: COMPARATOR
Intervention: multidrug chemotherapy schedule without VM26 and AraC
Number of subjects: 21
Study: 7428403

Group type: EXPERIMENTAL
Intervention: Prophylactic cephazolin sodium (1 g) given intramuscularly
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Prophylactic cephazolin sodium (1 g) given intravenously
Number of subjects: 690

Group type: COMPARATOR
Intervention: No treatment or placebo
Number of subjects: 690
Study: 31005919

Group type: EXPERIMENTAL
Intervention: Guided physical exercise and dietary therapy
Number of subjects: 10
Study: 28374645

Group type: EXPERIMENTAL
Intervention: Bromocriptine-QR (B-QR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bromocriptine-QR (B-QR) in high-dose insulin subset
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25896104

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 5 mg twice daily for three days
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (identical capsules for three days)
Number of subjects: 43
Study: 24075920

Group type: EXPERIMENTAL
Intervention: rHA 135 μg
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: rHA 45 μg
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: rHA 45 μg with GLA/SE
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: rHA 15 μg with GLA/SE
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: rHA 7.5 μg with GLA/SE
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: rHA 3.8 μg with GLA/SE
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392

Group type: COMPARATOR
Intervention: rHA alone
Number of subjects: 392
Study: 21430194

Group type: EXPERIMENTAL
Intervention: Breastfeeding (or exclusively breastfeeding) at the beginning of each follow-up interval
Number of subjects: 17046

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 17046
Study: 19250094

Group type: EXPERIMENTAL
Intervention: Electrocardiogram-based algorithm
Number of subjects: 100
Study: 17277910

Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 14734701

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 9422

Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 9422
Study: 11708732

Group type: EXPERIMENTAL
Intervention: Virtual reality distraction
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Movie distraction
Number of subjects: 2

Group type: COMPARATOR
Intervention: No distraction
Number of subjects: 2
Study: 9315419

Group type: EXPERIMENTAL
Intervention: Vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9 (N-9)
Number of subjects: 12
Study: 7936969

Group type: EXPERIMENTAL
Intervention: Lighter balls (Tachikara Volley Lite) during skills progressions
Number of subjects: 72

Group type: COMPARATOR
Intervention: Regulation balls during skills progressions
Number of subjects: 72
Study: 3358884

Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride (10 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cholestyramine (8 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Activated charcoal (8 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water only
Number of subjects: 6
Study: 31146613

Group type: EXPERIMENTAL
Intervention: RBAC (3 grams/day for 6 months)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (3 grams/day for 6 months)
Number of subjects: 47
Study: 30337307

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bronchoscopic lung volume reduction with endobronchial valves
Number of subjects: 0
Study: 27316668

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 24725374

Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Qualitative data
Number of subjects: 301
Study: 22282257

Group type: EXPERIMENTAL
Intervention: Computer aided cervical vertebra landmarking (CACVL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Orthodontic experts (OE) group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Orthodontic novices (ON) group
Number of subjects: 120
Study: 19937954

Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 244

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 244
Study: 19059175

Group type: EXPERIMENTAL
Intervention: Monthly simulated and critiqued oral examinations (MSCE) from 2003 to 2006 classes
Number of subjects: 48

Group type: COMPARATOR
Intervention: Historical control group (2001 and 2002 classes) without MSCE
Number of subjects: 48
Study: 15857065

Group type: EXPERIMENTAL
Intervention: Amine fluoride/stannous fluoride (AmF/SnF2) mouthwash
Number of subjects: 33

Group type: COMPARATOR
Intervention: Chlorhexidine (CHX) mouthwash
Number of subjects: 33
Study: 12215465

Group type: EXPERIMENTAL
Intervention: Omapatrilat (40 or 80 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fosinopril/Hydrochlorothiazide (FOS/HCTZ; 20 and 12.5 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 10405084

Group type: EXPERIMENTAL
Intervention: Elderly depressed patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 40
Study: 7725767

Group type: EXPERIMENTAL
Intervention: 0.5 mg PGE2 intracervical gel
Number of subjects: 79

Group type: COMPARATOR
Intervention: 3 mg PGE2 vaginal tablet
Number of subjects: 79
Study: 2175140

Group type: EXPERIMENTAL
Intervention: beta-endorphin infusion at 1 microgram.kg‐1.min‐1
Number of subjects: 7

Group type: COMPARATOR
Intervention: placebo (normal saline) infusion
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: beta-endorphin infusion
Number of subjects: 7
Study: 6994086

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30885626

Group type: EXPERIMENTAL
Intervention: Microbial cultivation with sonication pretreatment in 4 sVHD patients
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Metagenome analysis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Histological staining
Number of subjects: 25
Study: 29068865

Group type: EXPERIMENTAL
Intervention: Dynamic Integrated Movement Enhancement (DIME)
Number of subjects: 1068

Group type: COMPARATOR
Intervention: Army Preparation Drill (PD)
Number of subjects: 1068
Study: 25731923

Group type: EXPERIMENTAL
Intervention: BREAKS (2-min of treadmill walking at 3.2 km/h every 20 min for a total of 17 breaks/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: SIT (7-h days of uninterrupted sitting)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: BREAKS
Number of subjects: 19

Group type: COMPARATOR
Intervention: SIT
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: SIT and BREAKS
Number of subjects: 19
Study: 24405833

Group type: EXPERIMENTAL
Intervention: Adalimumab (20 mg/0.8 ml for patients <30 kg or 40 mg/0.8 ml for patients ≥30 kg, subcutaneous injection every 2 weeks)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo (0.8 ml as appropriate according to body weight, subcutaneous injection every 2 weeks)
Number of subjects: 154
Study: 23095489

Group type: COMPARATOR
Intervention: 1 session of HF-rTMS
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 10 sessions of HF-rTMS
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 21
Study: 19708804

Group type: EXPERIMENTAL
Intervention: Hypno-analgesia intervention
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 350
Study: 17709835

Group type: EXPERIMENTAL
Intervention: Low-dose multi-detector row CT (30 mAs, 16 detector rows, 0.75-mm section thickness)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Low-dose multi-detector row CT
Number of subjects: 157
Study: 15188172

Group type: COMPARATOR
Intervention: KLH feeding (50 and 250 mg) before immunization and booster in normal controls (n = 21)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: KLH feeding in patients with Crohn's disease (n = 12)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: KLH feeding in patients with ulcerative colitis (n = 13)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Immunization in normal controls (n = 21)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oral administration in patients with Crohn's disease (n = 12)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oral administration in patients with ulcerative colitis (n = 13)
Number of subjects: 45
Study: 11552143

Group type: EXPERIMENTAL
Intervention: Medically necessary dental services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dental treatment interventions
Number of subjects: 0
Study: 9688443

Group type: EXPERIMENTAL
Intervention: Loading dose of ticlopidine (1500 mg followed by 250 mg twice daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard ticlopidine treatment (250 mg twice daily)
Number of subjects: 18
Study: 8010796

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia
Number of subjects: 20
Study: 2642691

Group type: EXPERIMENTAL
Intervention: Intravenous clomipramine hydrochloride (150 mg) and placebo tablets
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral clomipramine hydrochloride (150 mg) and isotonic saline infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Intravenous clomipramine hydrochloride (200 mg) and placebo tablets
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral clomipramine hydrochloride (200 mg) and isotonic saline infusion
Number of subjects: 22
Study: 10564

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 14
Study: 31107823

Group type: EXPERIMENTAL
Intervention: Living Donor Liver Transplantation (LDLT) for ALD
Number of subjects: 168
Study: 25843498

Group type: COMPARATOR
Intervention: Home visit strategy by trained community health workers (CHWs) with five home visits (two during pregnancy and three after birth) and health facility strengthening.
Number of subjects: 0
Study: 23451166

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 749

Group type: COMPARATOR
Intervention: Lifestyle advice control
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with ≥5% weight loss at one year
Number of subjects: 749
Study: 21527582

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D levels 50 to <75 nmol/L
Number of subjects: 340

Group type: COMPARATOR
Intervention: Serum 25(OH)D levels <25 nmol/L
Number of subjects: 340
Study: 19160533

Group type: EXPERIMENTAL
Intervention: Eskimo Skin Care (oral oil formulation rich in natural stable fish oil)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 16926560

Group type: EXPERIMENTAL
Intervention: Simulation training with the Procedicus, computer-based, haptic simulator
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no simulation training)
Number of subjects: 20
Study: 14994317

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (mean dose 184.5 mg/d, range 130-234 mg/d)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba
Number of subjects: 39
Study: 11460611

Group type: EXPERIMENTAL
Intervention: Test Dentifrice (new calculus-inhibiting dentifrice with pyrophosphate, tripolyphosphate, copolymer in a 0.243% sodium fluoride/silica base)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Aquafresh Whitening Toothpaste with Fluoride
Number of subjects: 128

Group type: COMPARATOR
Intervention: Crest Regular Fluoride Toothpaste
Number of subjects: 128
Study: 9165969

Group type: EXPERIMENTAL
Intervention: 50 mg tetrahydrocannabinol daily in five doses during active weeks
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 1389952

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IPB) 240 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IPB) 120 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10273957

Group type: EXPERIMENTAL
Intervention: Practitioner-initiated minimal-contact intervention
Number of subjects: 213

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 213
Study: 29895679

Group type: EXPERIMENTAL
Intervention: Short-term intervention (STI) with 2 training sessions
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Long-term intervention (LTI) with a 14-week gradual transition
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 38
Study: 27934805

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 400 µg/day for 2 months
Number of subjects: 85

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 400 µg/day for 2 months
Number of subjects: 85
Study: 25374052

Group type: EXPERIMENTAL
Intervention: Suture (8-0 vicryl sutures)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Autologous in situ blood coagulum
Number of subjects: 90
Study: 22522750

Group type: EXPERIMENTAL
Intervention: Watch PAT monitoring
Number of subjects: 56
Study: 20234138

Group type: EXPERIMENTAL
Intervention: Nasal feeding tube (5-Fr) for 12 hours
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oral feeding tube (5-Fr) for 12 hours
Number of subjects: 32
Study: 18926145

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Narrower composite CV outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended composite CV outcomes
Number of subjects: 0
Study: 16095140

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for house dust mites (HDMs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated atopic patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 15456073

Group type: EXPERIMENTAL
Intervention: Intraoperative tracking of the trunk using magnetic sensors
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Positioning on the Relton-Hall frame
Number of subjects: 40
Study: 11034945

Group type: EXPERIMENTAL
Intervention: Genome-wide scan with 420 markers (353 microsatellites and 67 restriction fragment length polymorphisms) for systolic BP
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Genome-wide scan with 420 markers
Number of subjects: 206
Study: 8932660

Group type: EXPERIMENTAL
Intervention: High Anger-out subscale (AOS) men during recovery
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low Anger-out subscale (AOS) women during recovery
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Men who expressed much anger during harassment
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Women who expressed little anger during harassment
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: High AOS men and low AOS women
Number of subjects: 63
Study: 1539743

Group type: EXPERIMENTAL
Intervention: Vaccination with formalin‐killed Rickettsia rickettsii
Number of subjects: 51

Group type: COMPARATOR
Intervention: Challenge with Rickettsia rickettsii
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Postvaccination LT response
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Skin tests using killed R. rickettsii as antigen
Number of subjects: 51
Study: 2865153

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Lipophilic beta-blockers (metoprolol and propranolol)
Number of subjects: 14
Study: 30868496

Group type: EXPERIMENTAL
Intervention: Early partial weightbearing (Group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Delayed weightbearing (Group B)
Number of subjects: 42
Study: 29746426

Group type: EXPERIMENTAL
Intervention: Nonablative fractional 1565-nm Er:glass laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Picosecond fractional 1064/532-nm Nd:YAG laser
Number of subjects: 20
Study: 27098066

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 20min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study: 25487353

Group type: EXPERIMENTAL
Intervention: Intermediate care in nursing home unit with increased staff and multidisciplinary assessment for a maximum stay of three weeks
Number of subjects: 376

Group type: COMPARATOR
Intervention: Usual care in hospital
Number of subjects: 376
Study: 22795881

Group type: EXPERIMENTAL
Intervention: Preoperative music intervention for 30 minutes before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Preoperative music intervention
Number of subjects: 60
Study: 20388196

Group type: EXPERIMENTAL
Intervention: Gatekeeper training (QPR)
Number of subjects: 11000

Group type: EXPERIMENTAL
Intervention: Awareness training on mental health promotion for adolescents
Number of subjects: 11000

Group type: EXPERIMENTAL
Intervention: Screening for at-risk adolescents by health professionals
Number of subjects: 11000

Group type: COMPARATOR
Intervention: Minimal intervention (control group)
Number of subjects: 11000
Study: 18541129

Group type: EXPERIMENTAL
Intervention: Generic orlistat (Ranbaxy Laboratories) 120 mg, 3 times daily for 10 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Innovator orlistat (Xenical, Roche Laboratories) 120 mg, 3 times daily for 10 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Baseline (before treatment)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison of generic to innovator
Number of subjects: 18
Study: 15969876

Group type: EXPERIMENTAL
Intervention: FEX 180 mg/PSE 240 mg combination tablet
Number of subjects: 0

Group type: COMPARATOR
Intervention: FEX 180 mg immediate-release tablet and PSE 240 mg extended-release tablet (control)
Number of subjects: 0
Study: 14662201

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (100 mg twice a day, 6 days a month for 6 months)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (100 mg twice a day, 6 days a month for 6 months)
Number of subjects: 180
Study: 10319782

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% (R0.5 group)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.25% (R0.25 group)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% (B0.25 group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: All groups (R0.5, R0.25, B0.25)
Number of subjects: 56
Study: 8952866

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day for one month
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fluvastatin (exact dosage not specified) for one month
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normocholesterolemic subjects)
Number of subjects: 20
Study: 31493123

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 0
Study: 29666135

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy followed by radical radiotherapy (RRT) and stereotactic ablative radiotherapy (SABR) to the primary tumour and SABR/stereotactic radiosurgery (SRS) to all other metastatic sites
Number of subjects: 340

Group type: COMPARATOR
Intervention: Standard platinum-doublet chemotherapy only
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy followed by RRT/SABR
Number of subjects: 340
Study: 27404028

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens/bazedoxifene (two doses)
Number of subjects: 318
Study: 24463231

Group type: EXPERIMENTAL
Intervention: Lokomat robotic training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional home exercise
Number of subjects: 22
Study: 22435765

Group type: EXPERIMENTAL
Intervention: Five-step implementation process for an acute myocardial infarction clinical pathway (CPW)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 108